| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.0065 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |